[{"Assets_0_Q1_USD":1736558000.0,"CommonStockSharesOutstanding_0_Q1_shares":155003983.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-26838000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":225150000.0,"StockholdersEquity_0_Q1_USD":1155891000.0,"Ticker":"ALKS","CIK":"1520262","name":"ALKERMES PLC.","OfficialName":"Alkermes plc Ordinary Shares","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4612884468.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180426"}]